Abbreviations
RS, LKS, LMS, Rhinosinusitis, CRSsNP, CRS, polyps, COPD
CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, RECURRENCE, ALLERGY, RHINOSINUSITIS, CHRONIC RHINOSINUSITIS, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COPD, ASPIRIN EXACERBATED RESPIRATORY DISEASE, ADVERSE EVENT
AE, adverse event; AERD, aspirin exacerbated respiratory disease; BID, twice daily; COPD, chronic obstructive pulmonary disease; CRS, chronic rhinosinusitis; CRSsNP, chronic rhinosinusitis without polyps; CRSwNP, chronic rhinosinusitis with nasal polyps; CST1/2, cystatin-SA/SN; CT, computed tomography; ELISA, Enzyme Linked ImmunoSorbent Assay; FESS, functional endoscopic sinus surgery; GQOL, general quality of life; HRQoL, health related quality of life; ICAR : RS, International Consensus Statement on Allergy and Rhinology: Rhinosinusitis; IgE, Immunoglobulin E; LKS, Lund-Kennedy-Score; LMM, Linear mixed model; LMS, Lund-Mackay-Score; MMP9, Matrix metalloproteinase 9; MBL, mucus biomarker level; MCID, minimal clinically relevant different; NPS, Nasal Polyp Score; OR, odds ratio; PAPP-A, pappalysin-1; PGE2, Prostaglandin E2; POD, postoperative day; RSDI, Rhinosinusitis Disability Index; RR, recurrence rate; SAE, severe adverse event; SF-36, Short Form 36 Questionnaire; SNOT-22, sinonasal outcome test 22; SNQOL, sinonasal quality of life; SS, smell scores.